TransMedics Group, Inc. (TMDX)
Latest news, insights and market data
Market Data
$0.00
$76.51 (-100.00%)
Previous Close: $76.51
52-Week Range
0% from low
$64.85$83.29
AI Insights
No news
Updated about 1 hour ago
Latest News
| Title | Published |
|---|---|
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline | 6 days ago |
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference | 6 days ago |
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for | 7 days ago |
UBS Initiates TransMedics Group at Neutral With $80 Price Target UBS Initiates TransMedics Group at Neutral With $80 Price Target | 7 days ago |
TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum TransMedics Group (TMDX) combines strong earnings growth with a reasonable valuation, making it an affordable growth play in medical technology. | 7 days ago |
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026 | 13 days ago |
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut? Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut? | 27 days ago |
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
6 days ago
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
6 days ago
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate TransMedics (TMDX) to Report a Decline in Earnings: What to Look Out for
7 days ago
UBS Initiates TransMedics Group at Neutral With $80 Price Target
UBS Initiates TransMedics Group at Neutral With $80 Price Target
7 days ago
TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum
TransMedics Group (TMDX) combines strong earnings growth with a reasonable valuation, making it an affordable growth play in medical technology.
7 days ago
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
13 days ago
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?
Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?
27 days ago